Database of veterinary systematic reviews
Life Sci (2021) 265: 118813
DOI: 10.1016/j.lfs.2020.118813
AIMS: Although chemotherapeutic agents have highly beneficial effects against cancer, they disturb the body’s normal homeostasis. One of the critical side effects of chemotherapeutic agents is their deleterious effect on the cardiac system, which causes limitations of their clinical usage. Taurine constitutes more than 50% of the amino acids in the heart. The use of taurine might prevent chemotherapy-induced cardiotoxicity. This systematic study aims to evaluate the protective role of taurine against cardiotoxicity induced by chemotherapy. METHODS: A systematic search was performed in databases up to November 2020, and the review is designed on PRISMA guidelines. The search keywords were selected based on our study target and were searched in the title and abstract. After the consecutive screening, out of a whole of 94 articles, 8 articles were included according to our inclusion and exclusion criteria. KEY FINDINGS: According to the study results, chemotherapy decreases body and heart weight and increases mortality. Also, it induces some biochemical and histological changes compared to the control group. By co-administration of taurine with chemotherapy, alterations returned near to the average level. These protective effects of taurine are mediated through anti-oxidant, anti-inflammatory, and anti-apoptotic properties. SIGNIFICANCE: Based on evaluated non-clinical studies, taurine ameliorates chemotherapy-induced cardiotoxicity, but its possible interaction with the efficacy of anti-cancer medicines that mostly act through induction of oxidants remains to be elucidated in the future. This needs conducting well-designed studies to assess the effectiveness and safety of this combination simultaneously.
Samadi, M., Haghi-Aminjan, H., Sattari, M., Hooshangi Shayesteh, M. R., Bameri, B., Armandeh, M., Naddafi, M., Eghbal, M. A., & Abdollahi, M. (2021). The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study. Life Sci, 265, 118813. https://doi.org/10.1016/j.lfs.2020.118813 Animals, Humans, Apoptosis/drug effects, Cisplatin, Antioxidants/administration & dosage/pharmacology, Anti-Inflammatory Agents/administration & dosage/pharmacology, Antineoplastic Agents/administration & dosage/*adverse effects, Cardiotoxicity/etiology/*prevention & control, Cyclophosphamide, Doxorubicin, Neoplasms/drug therapy, Systemic review, Taurine, Taurine/*administration & dosage/pharmacology